Importantly for the availability of coverage across the workforce, the share of firms with 5,000 or more workers covering these medications for weight loss increased significantly over the last year (from 28% in 2024 to 43% in 2025)
The higher the dose of Trulicity the greater the weight loss with the highest 4.5mg dose associated with about 4.7kg weight loss
Eli Lilly looks to be the closest, with positive results from phase 3 clinical trials of its once-a-day pill orforglipron emerging in April, June and August
On Android, data is stored securely in Google Firebase
Tirzepatide, followed by semaglutide, is the most likely to cause nausea and vomiting
Promising studies also have examined the use of GLP-1s in the treatment of alcohol and drug addiction